abstract |
There is provided a series of novel .alpha.-(N-sulfonamido)acetamide compounds of the Formula (I) wherein R, R1, R2 and R3 are defined herein, which are inhibitors of .beta.-amyloid peptide (.beta.-AP) production and are useful in the treatment of Alzheimer's Disease and other conditions affected by anti-amyloid activity. |